Switch Language
Alt tag
Bayer Logo Bayer Logo Bayer Logo

Welcome to Thrombosis Adviser

A Venous & Arterial Thrombosis Resource

Latest in Thrombosis

Renal preservation
Going one step further: Renal preservation in patients with artial fibrillation
2020_1_15_TA_VTE_Home_treatment_with_PE_newsletter
When is the right time to start thinking about renal function in patients with AF?
2021_1_05_TA_ICHTIC_congress_newsletter
International Conference on Thrombosis and Hemostasis Issues in Cancer 2021
2020_1_22_TA_VTE_Extended_treatment_tailoring_newsletter
Extended Treatment for VTE: Tailoring Treatment for Patients Who Need it

Latest in Thrombosis

2020_2_04_TA_ESC_2020_congress
Thrombosis Adviser at the European Society of Cardiology Congress 2020
Study teaser image
Paediatric patients with VTE: Protecting the most challenging population
Study teaser image
Thrombosis Adviser at the European Society of Cardiology Congress 2019
Study teaser image
Making connections: Stroke risk in patients with multiple co-morbidities

Latest in Thrombosis tb

2020_2_04_TA_ESC_2020_congress
Thrombosis Adviser at the European Society of Cardiology Congress 2020
Study teaser image
Paediatric patients with VTE: Protecting the most challenging population
Study teaser image
Thrombosis Adviser at the European Society of Cardiology Congress 2019
Study teaser image
Making connections: Stroke risk in patients with multiple co-morbidities

Listen to the Thrombosis Adviser Podcast Series

Going one step further: Renal preservation in patients with artial fibrillation 

Find out why renal decline is an important issue for patients with AF and how they can be protected

 

Approval code: PP-M_RIV-ALL-0104-1

 

Check out our story
Renal preservation

Never miss out on the latest news!

Over 4,000 healthcare professionals have already signed up.

Aspirin, Einstein
Choice and long-term
VTE treatment

YYMMDD Author/Uploaded by

Professor Paolo Prandoni looks at the role of ASA in extended VTE treatment and discusses the recent EINSTEIN CHOICE study, which compared two doses of rivaroxaban to ASA for extended VTE treatment.

Approval number PP-XAR-ALL-1747-1

Latest in Thrombosis

ThrombosisAdviser at
the European Society of
Cardiology Congress 2019

The European Society of Cardiology (ESC) congress is the largest cardio-vascular congress in the world. This year’s event also included the World Congress of Cardiology and attracted over 30,000 delegates, who gathered at the Paris Expo Porte de Versailles to participate in a programme of over 500 different sessions across the full spectrum of cardiovascular medicine. As ever, a large amount of the data and discussion focused on prevention of stroke in patients with atrial fibrillation (AF), reflecting the huge burden of this disease around the world.

Read more
Alt tag

Aspirin, Einstein
Choice and long-term
VTE treatment

YYMMDD Author/Uploaded by

Professor Paolo Prandoni looks at the role of ASA in extended VTE treatment and discusses the recent EINSTEIN CHOICE study, which compared two doses of rivaroxaban to ASA for extended VTE treatment.

Approval number PP-XAR-ALL-1747-1

Join the conversation!

Thrombosis Connection, A Healthcare Professionals’ Forum
welcomes individuals interested in sharing, developing and
fostering innovative solutions in the field of thrombosis.